Lopinavir (LPV) Dose Reduction

NCT01159275 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infections

Interventions

DRUG: Generic LPV/r and Aluvia (pharmacokinetics)
DRUG: Aluvia and Generic LPV/r (pharmacokinetics)

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators

[object Object]